DrugsControl Media Services
DrugsControl.org

News Detail

DCGI bans manufacturing, sale, distribution of ulipristal acetate tablets 5 mg (17-11-2020)

Mumbai, 17 Nov 2020: The Drugs Controller General of India (DCGI) has directed the state licensing authorities (SLAs) to direct manufacturers to suspend the manufacturing, sale or distribution of ulipristal acetate tablets 5 mg based on the recommendation of European Medicines Ag......
View Details

Source : Pharmabiz

Related News